Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (4): 374-381.doi: 10.3736/jcim20110405

• Original Clinical Research • Previous Articles     Next Articles

Biochemical characteristics of traditional Chinese medicine syndromes and their elements in patients with hepatitis B cirrhosis

Ji-li Yuan1, Hua Zhang1, Lei Wang2, Yan Lin1, Xin-cai Hu1, Qin Zhang2, Ping Liu1,3()   

  1. 1. Institute of Liver Diseases, Shuguang Hospital, Key Laboratory of Liver and Kidney Diseases of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    2. Department of Liver Diseases, Shanghai Public Health Center, Shanghai 201508, China
    3. E-Institute of Traditional Chinese Internal Medicine, Shanghai Municipal Education Commission, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2010-11-25 Accepted:2011-01-10 Online:2011-04-20 Published:2011-04-15
  • Contact: Liu Ping E-mail:liuliver@vip.sina.com

Objective: To investigate the characteristics of traditional Chinese medicine (TCM) syndromes and their elements in patients with posthepatitic cirrhosis by analyzing the relationships between signs and symptoms and biochemical parameters.
Methods: A total of 440 patients with hepatitis B cirrhosis treated in Shanghai Public Health Center and Shuguang Hospital, Longhua Hospital and Central Hospital of Putuo District Affiliated to Shanghai University of Traditional Chinese Medicine during January 2002 to January 2006 were enrolled in this study. Signs and symptoms and biochemical information of patients were collected by using a self-designed questionnaire regarding the four examinations of TCM. Signs and symptoms were firstly analyzed to find the frequency of occurrence. Then, the patients were divided into two groups according to non-existent or existent sign and symptom and the correlations between the signs and symptoms which occurred most frequently and their biochemical parameters were analyzed.
Results: Sixteen symptoms which occurred most frequently were fatigue, colored urine, liver palms, opaque complexion, string-like pulse, weakness at waist and knees, dry month and bitter taste in the mouth, profuse dreaminess and poor sleepiness, heaviness of limbs, abdominal distention, yellow eyes, fine pulse, impetuosity and susceptibility to rage, splenomegaly, poor appetite, and distension and fullness in the chest and hypochondrium. A previous study on syndrome differentiation of 900 patients with posthepatitic cirrhosis showed 4 syndrome patterns: internal accumulation of dampness-heat, liver-kidney yin deficiency, internal accumulation of blood stasis-heat, and liver depression and spleen deficiency. Further analysis showed that internal accumulation of dampness-heat syndrome was characterized by obvious hepatic inflammation, poor synthesis function and more asctites. Liver-kidney yin deficiency syndrome was characterized by low-level hepatic inflammation, poor synthesis function and more ascites. Internal accumulation of blood stasis-heat syndrome was characterized by low-level hepatic inflammation, poorer synthesis function, ascites and splenomegalia, and liver depression and spleen deficiency syndrome was characterized by slight hepatic inflammation, synthesis function injury, decreased internal portal vein diameter and less ascites.
Conclusion: Different syndrome patterns have different pathological features, showing the complexity and polymorphism of syndrome construction.

Key words: posthepatitis cirrhosis, syndrome, pathological conditions, signs and symptoms, biological parameters, clinical trial

"

Table 2

Relationships between main signs and symptoms and experimental parameters of 440 patients with posthepatitic cirrhosis (x±s)"

Sign or
symptom
Cr
(μmol/L)
BUN
(mmol/L)
TAG
(mmol/L)
TC
(mmol/L)
ALT
(IU/L)
AST
(IU/L)
GGT
(IU/L)
ALP
(IU/L)
ChE
(kU/L)
TBil
(μmol/L)
ALB
(g/L)
G
(g/L)
ApoA
(g/L)
PT
(s)
AFP
(ng/mL)
Portal vein
(mm)
Spleen
(mm)
Ascites
Fatigue
No 72±15 4.7±1.6 1.4±0.6 4.3±1.5 72±74 71±55 88±72 172±116 5.6±3.0 43±67 35.1±7.9 34.2±6.1 0.98±0.38 16.2±3.1 37.4±88.6 13.2±1.8 48.7±11.1 0.85±0.90
Yes 79±27 5.1±3.2 1.3±0.7 4.0±1.3 77±72 89±76 82±75 187±130 5.2±3.3 55±58 34.4±8.0 35.9±7.4 0.89±0.36 17.1±4.0 56.6±93.2 12.6±1.8 48.7±13.3 0.93±1.07
Z –1.875 –0.770 –2.094 –1.047 –1.539 –2.176 –0.926 –1.376 –1.246 –1.945 –0.894 –1.945 –2.019 –1.571 –3.295 –2.708 –0.147 –0.237
P 0.061 0.441 0.036 0.295 0.124 0.030 0.355 0.169 0.213 0.052 0.371 0.052 0.044 0.116 0.001 0.007 0.883 0.813
Yellow urine
No 76±27 5.2±2.0 1.5±0.7 4.5±1.5 73±113 66±68 71±65 149±80 5.6±2.8 30±58 38.3±7.4 34.1±7.1 1.03±0.35 14.9±2.3 32.0±53.6 12.9±1.7 45.7±12.1 0.57±0.82
Yes 78±24 5.0±3.2 1.3±0.7 3.9±1.3 97±121 109±133 93±100 203±171 5.1±3.4 66±76 33.3±7.7 36.1±7.2 0.86±0.36 17.5±4.0 60.0±101.5 12.7±1.9 49.7±13.0 1.03±1.07
Z –1.020 –2.081 –3.505 –3.975 –3.410 –5.484 –2.281 –3.406 –1.948 –8.327 –6.208 –2.791 –4.111 –6.752 –2.816 –1.133 –2.691 –3.887
P 0.308 0.037 0.000 0.000 0.001 0.000 0.023 0.001 0.051 0.000 0.000 0.005 0.000 0.000 0.005 0.257 0.007 0.000
Liver palms
No 77±24 5.0±1.8 1.4±0.7 4.3±1.5 88±119 87±93 83±84 213±241 6.1±4.8 52±67 36.0±7.5 34.7±7.8 0.96±0.38 16.0±3.4 55.1±101.0 13.0±1.4 48.5±12.9 0.68±1.01
Yes 77±25 5.1±3.2 1.3±0.7 4.0±1.3 92±120 102±129 89±96 182±111 5.0±2.5 59±76 34.0±8.1 35.9±7.0 0.89±0.35 17.1±3.9 52.2±89.8 12.7±2.0 48.8±12.9 1.00±1.03
Z –0.138 –1.053 –1.980 –2.121 –0.043 –1.359 –0.441 –0.542 –2.774 –2.087 –2.564 –1.879 –1.711 –2.771 –0.290 –1.839 –0.704 –3.151
P 0.891 0.292 0.048 0.034 0.966 0.174 0.659 0.588 0.006 0.037 0.010 0.060 0.087 0.006 0.772 0.066 0.481 0.002
Opaque complexion
No 77±22 5.1±4.1 1.5±1.0 4.2±1.4 144±164 146±184 112±117 237±172 5.8±3.2 67±83 35.1±7.7 36.1±7.5 0.90±0.33 17.6±4.5 67.1±113.0 12.7±2.0 46.4±12.9 0.73±1.09
Yes 78±26 5.0±2.1 1.3±0.5 4.0±1.3 70±89 79±78 78±80 171±144 5.1±3.3 53±69 35.3±8.1 35.4±7.1 0.91±0.38 16.6±3.5 47.4±82.8 12.7±1.8 49.7±12.8 0.99±1.00
Z –0.224 –1.230 –2.424 –1.275 –6.172 –5.741 –3.804 –6.014 –2.252 –1.982 –1.219 –0.909 –0.602 –1.742 –1.928 –0.457 –2.336 –3.167
P 0.822 0.219 0.015 0.202 0.000 0.000 0.000 0.000 0.024 0.047 0.223 0.363 0.547 0.082 0.054 0.648 0.019 0.002
Stringlike pulse
No 78±29 5.1±2.1 1.3±0.7 3.9±1.1 80±118 87±98 78±78 179±117 5.0±2.7 50±66 35.0±8.1 36.1±8.2 0.93±0.38 16.4±3.2 35.7±72.0 12.7±1.8 49.0±12.0 1.07±0.99
Yes 77±23 5.0±3.3 1.4±0.7 4.1±1.4 96±120 103±131 92±99 195±169 5.4±3.5 60±76 34.3±7.9 35.4±6.8 0.89±0.35 17.1±4.1 61.0±99.7 12.8±1.9 48.7±13.3 0.84±1.05
Z –0.242 –0.880 –2.743 –1.472 –2.098 –1.875 –2.123 –1.346 –1.302 –1.693 –1.064 –0.349 –0.721 –1.207 –2.799 –0.038 –0.360 –2.662
P 0.809 0.379 0.006 0.141 0.036 0.061 0.034 0.178 0.193 0.090 0.287 0.727 0.471 0.228 0.005 0.969 0.719 0.008
Weak at waist and knees
No 76±20 4.9±1.8 1.4±0.6 4.4±1.4 89±110 93±102 83±84 212±210 5.7±2.7 61±88 35.5±8.0 35.5±6.7 0.92±0.36 16.4±3.7 45.2±77.1 12.9±1.8 48.0±12.8 0.60±0.96
Yes 78±27 5.1±3.4 1.3±0.7 3.9±1.3 91±125 100±131 90±98 178±116 5.1±3.5 55±64 34.0±7.9 35.6±7.5 0.90±0.36 17.7±3.9 57.0±99.6 12.6±1.8 49.1±13.0 1.08±1.04
Z –0.158 –0.381 –2.810 –2.976 –0.178 –1.077 –0.850 –2.424 –3.135 –0.280 –1.796 –0.208 –0.883 –1.872 –0.149 –1.105 –0.639 –5.147
P 0.875 0.703 0.005 0.003 0.859 0.281 0.395 0.015 0.002 0.780 0.072 0.835 0.377 0.061 0.882 0.269 0.523 0.000
Dry month and bitter taste in the mouth
No 78±26 5.2±4.1 1.3±0.6 4.2±1.5 110±149 127±172 98±105 230±214 5.3±2.7 64±79 33.9±8.4 36.4±7.9 0.85±0.37 17.3±4.1 63.5±109.0 12.8±1.8 49.1±13.8 0.76±1.05
Yes 77±24 4.9±2.0 1.3±0.7 4.0±1.3 80±98 82±76 82±86 167±104 5.2±3.8 53±70 34.9±7.7 35.1±6.8 0.94±0.35 16.6±3.6 47.0±81.8 12.7±1.7 48.5±12.3 1.00±1.02
Z –0.329 –0.481 –0.394 –0.825 –2.115 –3.081 –1.514 –4.538 –0.997 –2.129 –1.554 –1.508 –2.536 –2.190 –2.003 –0.613 –1.176 –2.891
P 0.742 0.630 0.693 0.410 0.034 0.002 0.130 0.000 0.319 0.033 0.120 0.131 0.011 0.029 0.045 0.540 0.240 0.004
Profuse dreaminess and poor sleepiness
No 80±24 4.9±2.2 1.4±0.7 4.2±1.4 98±123 105±122 99±111 203±167 5.4±2.7 58±65 34.9±7.5 35.1±6.5 0.76±1.07 16.6±3.9 56.5±81.7 12.9±1.7 49.0±11.8 0.76±1.07
Yes 76±26 5.1±3.3 1.3±0.7 4.0±1.3 86±118 93±121 81±79 181±147 5.2±3.6 57±78 34.3±8.3 35.9±7.6 1.02±1.01 17.0±3.8 50.7±98.9 12.9±1.8 48.5±13.6 1.02±1.01
Z –1.594 –0.162 –1.401 –1.213 –1.785 –0.473 –1.440 –2.726 –1.354 –0.500 –1.034 –0.984 –1.773 –1.159 –2.972 –0.007 –0.372 –3.259
P 0.111
0.871
0.161
0.225
0.074
0.636
0.150 0.006 0.176 0.617 0.301 0.325 0.076 0.246 0.003 0.994 0.710 0.001
Heaviness of limbs
No 73±19 5.0±1.8 1.3±0.6 4.3±1.3 77±92 82±85 83±85 171±153 5.4±3.9 45±64 36.1±7.5 34.6±6.5 0.99±0.35 15.7±3.0 40.5±76.1 12.8±1.9 47.5±12.7 0.89±0.94
Yes 81±29 5.1±3.6 1.3±0.7 3.9±1.3 103±139 112±145 92±100 206±156 5.2±2.6 68±79 33.1±8.1 36.4±7.7 0.83±0.36 17.8±4.2 63.9±104.0 12.7±1.8 49.8±13.0 0.94±1.12
Z –3.330 –0.884 –0.793 –3.035 –3.370 –4.373 –1.989 –4.616 –0.400 –4.032 –4.362 –2.962 –4.934 –5.766 –3.909 –0.799 –2.086 –0.351
P 0.001 0.377 0.428 0.002 0.001 0.000 0.047 0.000 0.689 0.000 0.000 0.003 0.000 0.000 0.000 0.424 0.037 0.726
Abdominal distention
No 75±18 4.8±1.7 1.4±0.6 4.4±1.3 79±33 82±67 83±70 178±96 5.5±3.8 54±76 36.2±8.0 35.0±6.8 0.94±0.37 16.2±3.3 43.2±72.7 12.8±1.9 47.5±13.1 0.67±0.84
Yes 80±30 5.3±3.8 1.2±0.7 3.8±1.3 70±63 83±65 76±60 177±107 5.0±2.6 60±71 33.0±7.6 36.1±7.6 0.87±0.35 17.5±4.2 62.3±108.0 12.7±1.7 50.0±12.6 1.16±1.15
Z –1.300 –0.651 –3.203 –5.101 –0.138 –1.432 –0.816 –0.723 –1.542 –1.400 –4.285 –1.611 –2.185 –3.435 –0.540 –0.658 –1.714 –4.336
P 0.194 0.515 0.001 0.000 0.890 0.152 0.414 0.470 0.123 0.161 0.000 0.107 0.029 0.001 0.589 0.511 0.087 0.000
Yellow eyes
No 73±20 4.9±1.7 1.4±0.6 4.4±1.3 76±102 72±82 76±67 170±157 5.9±3.8 29±42 38.1±7.6 34.7±7.2 1.02±0.36 15.0±2.3 34.1±62.8 12.8±1.6 46.4±11.0 0.65±0.86
Yes 81±28 5.2±3.8 1.3±0.8 3.7±1.3 106±134 124±147 99±112 209±151 4.7±2.4 85±87 30.9±6.5 36.5±7.1 0.79±0.33 18.7±4.2 71.9±112.0 12.7±2.0 51.1±14.2 1.19±1.12
Z –3.009 –1.097 –3.074 –6.195 –4.105 –7.769 –2.018 –3.963 –4.818 –12.900 –9.828 –3.133 –6.760 –10.53 –4.274 –0.557 –4.477 –5.012
P 0.003 0.273 0.002 0.000 0.000 0.000 0.044 0.000 0.000 0.000 0.000 0.002 0.000 0.000 0.000 0.578 0.000 0.000
Thin pulse
No 78±23 5.0±3.4 1.4±0.8 4.1±1.4 109±134 113±144 98±101 217±178 5.5±3.9 69±83 34.0±8.0 35.5±6.9 0.86±0.36 17.3±4.2 64.5±100.0 12.7±2.0 48.8±13.7 0.86±1.08
Yes 76±27 5.1±2.2 1.2±0.5 4.1±1.3 68±95 78±80 74±81 155±112 5.0±2.3 42±56 35.2±7.9 35.6±7.6 0.96±0.36 16.2±3.2 38.4±79.8 12.7±1.7 48.6±11.8 0.99±0.97
Z –0.925 –1.289 –1.813 –0.151 –4.965 –4.116 –4.067 –6.334 –0.541 –4.715 –1.748 –0.570 –2.882 –2.200 –4.973 –0.131 –0.332 –2.221
P 0.355 0.197 0.070 0.880 0.041 0.000 0.000 0.000 0.589 0.000 0.080 0.568 0.004 0.028 0.000 0.896 0.740 0.026
Impetuosity and susceptibility to rage
No 78±24 5.1±3.2 1.4±0.7 4.1±1.5 100±129 106±110 89±90 207±146 5.5±2.8 67±88 34.1±8.0 35.3±6.7 0.87±0.38 17.1±4.1 59.3±104.4 12.8±1.9 48.5±13.5 0.75±0.99
Yes 77±26 4.9±2.0 1.3±0.7 4.0±1.2 78±105 88±134 86±97 167±164 5.0±3.8 44±46 35.1±7.8 36.0±7.8 0.95±0.33 16.5±3.5 44.5±73.7 12.7±1.7 49.0±12.0 1.14±1.05
Z –0.025 –0.291 –2.558 –0.659 –2.465 –2.406 –0.755 –4.925 –2.443 –3.565 –1.656 –0.579 –2.470 –1.406 –2.147 –0.333 0.000 –4.177
P 0.980 0.771 0.011 0.510 0.014 0.016 0.450 0.000 0.015 0.000 0.098 0.563 0.016 0.160 0.032 0.739 1.000 0.000
Splenomegaly
No 76±17 5.0±3.3 1.4±0.7 4.3±1.4 102±119 111±144 98±106 221±175 5.9±3.8 63±86 35.3±7.6 36.2±7.2 0.89±0.36 16.9±4.0 61.2±101.0 12.7±1.9 45.8±13.3 0.61±0.97
Yes 79±33 5.1±2.5 1.2±0.7 3.7±1.2 74±119 80±76 73±69 146±107 4.5±2.1 48±60 33.4±8.3 34.7±7.2 0.92±0.37 16.8±3.6 41.1±77.5 12.8±1.7 53.3±10.8 1.35±0.97
Z –1.031 –0.238 –5.863 –4.588 –4.214 –2.614 –3.617 –8.052 –4.984 –0.644 –2.739 –2.189 –0.707 –0.255 –4.553 –1.774 –5.502 –8.363
P 0.302 0.812 0.000 0.000 0.000 0.009 0.000 0.000 0.000 0.520 0.006 0.029 0.480 0.799 0.000 0.076 0.000 0.000
Poor appetite
No 75±19 5.0±1.7 1.3±0.6 4.2±1.3 74±82 79±73 81±84 177±154 5.3±3.7 45±54 35.8±8.1 35.2±7.2 0.94±0.36 16.1±3.2 35.9±54.0 12.9±1.9 48.9±11.9 0.84±0.97
Yes 81±31 5.2±4.1 1.3±0.8 3.8±1.4 114±155 124±164 97±105 207±155 5.2±2.7 75±91 32.8±7.4 36.2±7.2 0.85±0.36 17.9±4.4 77.2±125.0 12.6±1.8 48.4±14.2 1.03±1.12
Z –1.610 –1.798 –1.389 –3.866 –3.191 –4.767 –2.174 –2.944 –0.109 –4.013 –4.003 –2.003 –2.253 –4.240 –3.428 –2.008 –0.375 –1.478
P 0.107 0.072 0.165 0.000 0.001 0.000 0.030 0.003 0.913 0.000 0.000 0.045 0.024 0.000 0.001 0.045 0.708 0.139
Hypochondriac pain
No 78±27 5.0±2.1 1.3±0.6 4.1±1.4 81±105 92±117 87±95 185±166 5.0±3.3 57±77 34.7±8.1 35.2±7.1 0.94±0.35 16.7±3.8 52.4±96.4 12.9±1.8 48.5±13.4 1.01±1.04
Yes 76±18 5.1±5.0 1.5±1.0 4.0±1.3 124±159 121±134 91±86 205±107 6.2±3.0 58±99 33.7±7.5 36.9±7.4 0.78±0.37 17.4±4.0 54.7±77.0 12.2±1.9 49.5±10.9 0.58±0.95
Z –0.032 –1.523 –1.995 –0.388 –2.691 –3.258 –1.717 –2.730 –3.652 –1.665 –1.115 –2.176 –4.076 –2.036 –1.521 –3.091 –0.577 –3.992
P 0.975 0.128 0.046 0.698 0.007 0.001 0.086 0.006 0.000 0.096 0.265 0.030 0.000 0.042 0.128 0.002 0.564 0.000
[1] Zhang Q, Zhang WT, Wei JJ, Wang XB, Liu P . Combined use of factor analysis and cluster analysis in classification of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis[J]. J Chin Integr Med, 2005,3(1):14-18
张琴, 张文彤, 魏建军, 王宪波, 刘平 . 公因子和聚类分析联合在肝炎后肝硬化证候分类研究中的应用[J]. 中西医结合学报, 2005,3(1):14-18
[2] Su Y, Wang L, Zhang H, Zhang Q, Lu YY, Liu P, Su SB . Analysis on similarity between traditional Chinese medicine syndromes and information on disease in patients with post-hepatitis cirrhosis[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2009,29(5):398-402
苏越, 王磊, 张华, 张琴, 陆奕宇, 刘平, 苏式兵 . 肝炎后肝硬化中医证候与疾病信息相似度分析[J]. 中国中西医结合杂志, 2009,29(5):398-402
[3] Chinese Society of Infections Diseases and Parasitology and Chinese Society of Hepatology,Chinese Medical Association. The program of prevention and treatment for viral hepatitis[J]. Zhonghua Nei Ke Za Zhi, 2001,4(1):62-68
中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华内科杂志, 2001,4(1):62-68
[4] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatology, 2010,53(3):397-417
doi: 10.1016/j.jhep.2010.05.004
[5] Liang KH, Li SB. Hepatology[M]. Beijing: People’s Medical Publishing House, 2003: 201-240
梁扩寰, 李绍白 . 肝脏病学[M]. 北京: 人民卫生出版社, 2003: 201-240
[6] Zhang Q, Liu P, Zhang HW, Wang L, Dou GL, Chen HF, Chen L, Wang JR, Wang XB . Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
张琴, 刘平, 章浩伟, 王磊, 都广礼, 陈慧芬, 陈良, 王江容, 王宪波 . 900例肝炎后肝硬化中医证候判别模式的研究[J]. 中国中西医结合杂志, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
[1] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[2] Zeinab Vafaeipour, Bibi Marjan Razavi, Hossein Hosseinzadeh. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. Journal of Integrative Medicine, 2022, 20(3): 193-203.
[3] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[4] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[5] Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.
[6] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[7] Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202.
[8] Dastan M. Khoshnaw, Abhijit A. Ghadge. Yoga as a complementary therapy for metabolic syndrome: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 6-12.
[9] Johannes Loeser, Brigitte Layer, Christopher Plata, Klaus-Maria Perrar, Tim Hucho, Rebecca Kulbida. Hirudotherapy attenuates arthritic pain in patients with various chronic pain syndromes: A retrospective analysis. Journal of Integrative Medicine, 2020, 18(5): 425-433.
[10] . External application of two unrestricted herbal medicines to treat costochondritis in a young collegiate athlete: A case report. Journal of Integrative Medicine, 2020, 18(5): 450-454.
[11] Shi-xin Wang, Yan Wang, Yu-bao Lu, Jie-yun Li, Yu-jun Song, Munkhtuya Nyamgerelt, Xue-xi Wang. Diagnosis and treatment of novel coronavirus infectious pneumonia based on the theory of traditional Chinese medicine. Journal of Integrative Medicine, 2020, 18(4): 275-283.
[12] Zi-jia Zhang, Wen-yong Wu, Jin-jun Hou, Lin-lin Zhang, Fei-fei Li, Lei Gao, Xing-dong Wu, Jing-ying Shi, Rong Zhang, Hua-li Long, Min Lei, Wan-ying Wu, De-an Guo, Kai-xian Chen, Lewis A. Hofmann, Zhonghua Ci. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis. Journal of Integrative Medicine, 2020, 18(3): 229-241.
[13] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[14] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[15] Pratya Phetkate, Tanawan Kummalue, Prasob-orn Rinthong, Somboon Kietinun, Kusuma Sriyakul. Study of the safety of oral Triphala aqueous extract on healthy volunteers. Journal of Integrative Medicine, 2020, 18(1): 35-40.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228